Skip to NavigationSkip to content

News

0
Shares in Canadian cannabis company Tilray jumped by more than 11% today after the British Columbia-based firm announced its entry into a global...
0
Private consultancy firms were paid at least £26 million as part of a reorganisation of the NHS, in what has been described as an “unacceptable”...
0
Israeli and South Korean-based drug makers Teva and Celltrion are set to move in on the market share occupied by Roche and Genentech’s Herceptin (...
0
A study has found that Eli Lilly’s Taltz (ixekizumab) met the primary and all secondary endpoints in patients with active psoriatic arthritis (PsA...

Features

2018 has been a year characterised by uncertainty, but also significant leaps in research, access, and industry deals. With 2019 bringing a host...